- Home
- COLL vs VMEO Comparison
COLL vs VMEO Comparison
Compare COLL & VMEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- VMEO
- Stock Information
- Founded
- COLL 2002
- VMEO 2004
- Country
- COLL United States
- VMEO United States
- Employees
- COLL N/A
- VMEO N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- VMEO Computer Software: Prepackaged Software
- Sector
- COLL Health Care
- VMEO Technology
- Exchange
- COLL Nasdaq
- VMEO Nasdaq
- Market Cap
- COLL 910.2M
- VMEO 832.5M
- IPO Year
- COLL 2015
- VMEO N/A
- Fundamental
- Price
- COLL $29.05
- VMEO $4.89
- Analyst Decision
- COLL Strong Buy
- VMEO Buy
- Analyst Count
- COLL 5
- VMEO 3
- Target Price
- COLL $43.60
- VMEO $8.67
- AVG Volume (30 Days)
- COLL 438.9K
- VMEO 1.2M
- Earning Date
- COLL 05-08-2025
- VMEO 05-05-2025
- Dividend Yield
- COLL N/A
- VMEO N/A
- EPS Growth
- COLL 43.56
- VMEO 19.88
- EPS
- COLL 1.86
- VMEO 0.16
- Revenue
- COLL $631,449,000.00
- VMEO $417,006,000.00
- Revenue This Year
- COLL $20.00
- VMEO $4.16
- Revenue Next Year
- COLL $3.93
- VMEO $6.76
- P/E Ratio
- COLL $15.63
- VMEO $33.69
- Revenue Growth
- COLL 11.41
- VMEO N/A
- 52 Week Low
- COLL $27.28
- VMEO $3.43
- 52 Week High
- COLL $42.29
- VMEO $7.90
- Technical
- Relative Strength Index (RSI)
- COLL 43.65
- VMEO 29.44
- Support Level
- COLL $29.01
- VMEO $5.31
- Resistance Level
- COLL $30.53
- VMEO $5.34
- Average True Range (ATR)
- COLL 0.88
- VMEO 0.16
- MACD
- COLL -0.01
- VMEO -0.02
- Stochastic Oscillator
- COLL 20.97
- VMEO 7.65
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About VMEO Vimeo Inc.
Vimeo Inc is the all-in-one video software solution, providing the full breadth of video tools through a software-as-a-service model. The comprehensive and cloud-based tools of the company empower its users to create, share, collaborate and communicate with video on a single, turnkey platform. The company derives its revenue from SaaS subscription fees paid by customers for subscription plans.